BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 29553973)

  • 1. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
    Katzman D; Sterman DH
    Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant pleural mesothelioma: an update on diagnosis and treatment options.
    Kondola S; Manners D; Nowak AK
    Ther Adv Respir Dis; 2016 Jun; 10(3):275-88. PubMed ID: 26873306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in treatment of mesothelioma.
    Maggioni C; Barletta G; Rijavec E; Biello F; Gualco E; Grossi F
    Expert Opin Pharmacother; 2016 Jun; 17(9):1197-205. PubMed ID: 27055148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of malignant pleural mesothelioma.
    Rodríguez Panadero F
    Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant Mesothelioma: Has Anything Changed?
    Kim RY; Sterman DH; Haas AR
    Semin Respir Crit Care Med; 2019 Jun; 40(3):347-360. PubMed ID: 31525810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates in Management of Malignant Pleural Mesothelioma.
    John A; O'Sullivan H; Popat S
    Curr Treat Options Oncol; 2023 Dec; 24(12):1758-1789. PubMed ID: 37975977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-tumor immunotherapy in malignant pleural mesothelioma].
    Scherpereel A; Willemin MC; Wasielewski E; Dhalluin X
    Rev Mal Respir; 2018 Apr; 35(4):465-476. PubMed ID: 29415822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant pleural mesothelioma: 2013 state of the art].
    Campbell K; Brosseau S; Reviron-Rabec L; Bergot E; Lechapt E; Levallet G; Zalcman G
    Bull Cancer; 2013 Dec; 100(12):1283-93. PubMed ID: 24225007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in malignant pleural mesothelioma evaluation and management.
    Ai J; Stevenson JP
    Oncologist; 2014 Sep; 19(9):975-84. PubMed ID: 25061089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma.
    Chen SE; Pace MB
    Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Concepts in the Treatment of Malignant Pleural Mesothelioma.
    Wald O; Sugarbaker DJ
    Annu Rev Med; 2018 Jan; 69():365-377. PubMed ID: 29029582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements.
    Christoph DC; Eberhardt WE
    Curr Opin Oncol; 2014 Mar; 26(2):171-81. PubMed ID: 24441503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic therapies for malignant pleural mesothelioma.
    Gomez D; Tsao AS
    Curr Treat Options Oncol; 2014 Dec; 15(4):683-99. PubMed ID: 25266654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Dilling T; Dobelbower M; Govindan R; Hennon M; Horn L; Jahan TM; Komaki R; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Sharma N; Swanson SJ; Stevenson J; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2016 Jul; 14(7):825-36. PubMed ID: 27407123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future developments in the management of malignant pleural mesothelioma.
    Zucali PA; De Vincenzo F; Simonelli M; Santoro A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
    Liu H; Wu L; Ji K; Wang W
    Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural mesothelioma.
    Ho L; Sugarbaker DJ; Skarin AT
    Cancer Treat Res; 2001; 105():327-73. PubMed ID: 11224994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management options for malignant pleural mesothelioma: clinical and cost considerations.
    Goudar RK
    Drugs; 2007; 67(8):1149-65. PubMed ID: 17521217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNAs in the diagnosis and treatment of malignant pleural mesothelioma--a short review.
    Sheff KW; Hoda MA; Dome B; Hegedus B; Klepetko W; Weiss GJ
    Microrna; 2012; 1(1):40-8. PubMed ID: 25048089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.